Mergent, Inc. Announces Changes to the HealthShares(TM) Metabolic-Endocrine Disorders Index
June 02 2008 - 5:41PM
PR Newswire (US)
NEW YORK, June 2 /PRNewswire/ -- Mergent, Inc., administrator for
the HealthShares(TM) Indexes, a series of 20 underlying indexes for
the HealthShares(TM) Exchange Traded Funds, today announced the
following changes effective on the opening of trading on Thursday,
June 5, 2008: NeuroSearch AS (Copenhagen: NEUR) will replace
Sirtris Pharmaceuticals, Inc. (NASDAQ:SIRT) in the HealthShares(TM)
Metabolic-Endocrine Disorders Index. Sirtris Pharmaceuticals, Inc.
is being acquired by GlaxoSmithKline plc (NYSE:GSK). Companies
included in the HealthShares(TM) Metabolic-Endocrine Disorders
Index are engaged in the research, clinical development and/or
commercialization of therapeutic agents for the treatment of a wide
variety of metabolic-endocrine disorders including, but not limited
to, diabetes, obesity, Syndrome X, growth deficiency and rare
lysosomal disorders. About Mergent Mergent, Inc., a Xinhua Finance
company (TSE Mothers: 9399; OTC ADRs: XHFNY), is the preferred
provider of business and financial data on global publicly listed
companies. Headquartered in Fort Mill, SC and New York City with
sales offices in key North American cities, Mergent also has a
strong global presence with offices in London, Shanghai, Tokyo,
Toronto and Sydney. Mergent's databases contain detailed equity,
debt and corporate action information on over 15,000 U.S. public
companies, 20,000 non-U.S. public companies and all U.S. municipal
bonds. For more than a century, Mergent has been providing
solutions to clients in the investment management, academic,
research and corporate information fields. Today, that unique
experience is combined with leading-edge technology to form a
robust, diverse product line that operates under Mergent's
umbrella. These include Mergent's Dividend Achievers Indices -- the
premier benchmark for long-term returns; Ford Equity Research -- a
leading independent investment research firm; Mergent Online -- a
powerful web-based research portal that provides critical business
information to support daily research and analysis; Mergent
Manuals, Handbooks and Investment Guides; in-depth municipal and
corporate fixed-income data, as well as end-of-day evaluation
pricing; EventsData -- providing real-time information on corporate
actions, dividend payouts, news and updates directly to client
desktops. For more information, please visit
http://www.mergent.com/ and http://www.dividendachievers.com/.
DATASOURCE: Mergent, Inc. CONTACT: Jean Dugan, Director of Sales,
Index Services of Mergent, Inc., +1-212-413-7712, Web site:
http://www.mergent.com/ http://www.dividendachievers.com/
Copyright
Sierra Natl BK Tehachapi Calif (MM) (NASDAQ:SIRT)
Historical Stock Chart
From May 2024 to Jun 2024
Sierra Natl BK Tehachapi Calif (MM) (NASDAQ:SIRT)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Sierra Natl BK Tehachapi Calif (MM) (NASDAQ): 0 recent articles
More Sirtris Pharmaceuticals (MM) News Articles